Literature DB >> 26121440

HISTORICAL AND CURRENT PERSPECTIVE IN THE USE OF THYROID EXTRACTS FOR THE TREATMENT OF HYPOTHYROIDISM.

James V Hennessey.   

Abstract

OBJECTIVE: To describe the history, refinements, implementation, physiology, and clinical outcomes achieved over the past several centuries of thyroid hormone replacement strategies.
METHODS: A Medline search was initiated using the following search terms: bioidentical thyroid hormone, thyroid hormone extract, combination thyroxine (T4) and tri-iodothyronine (T3) therapy, homeopathic thyroid hormone therapy, and thyroid hormone replacement. Pertinent articles of interest were identified by title (and where available abstract) for further review. Additional references were identified during a review of the identified literature.
RESULTS: A rich history of physician intervention in thyroid dysfunction was identified dating back more than 2 millennia. Although not precisely documented, thyroid ingestion from animal sources had been used for centuries but was finally scientifically described and documented in Europe over 130 years ago. Since the reports by Bettencourt and Murray, there has been a continuous documentation of outcomes, refinement of hormone preparation production, and updating of recommendations for the most effective and safe use of these hormones for relieving the symptoms of hypothyroidism. As the thyroid extract preparations contain both levothyroxine (LT4) and liothyronine (LT3), current guidelines do not endorse their use as controlled studies do not clearly document enhanced objective outcomes compared with LT4 monotherapy. Among current issues cited, the optimum ratio of LT4 to LT3 has yet to be determined, and the U.S. Food and Drug Administration (FDA) does not appear to be monitoring the thyroid hormone ratios or content in extract preparations on the market. Taken together, these limitations are important detriments to the use of thyroid extract products.
CONCLUSION: The evolution of thyroid hormone therapies has been significant over the extended period of time they have been in use to treat hypothyroidism. Although numerous websites continue to advocate the use of thyroid hormone extracts as a superior therapy for hypothyroidism, none of the most recent guidelines of major endocrine societies recommend thyroid extract use for hypothyroidism.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26121440     DOI: 10.4158/EP14477.RA

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  9 in total

1.  Pharmacokinetics of L-Triiodothyronine in Patients Undergoing Thyroid Hormone Therapy Withdrawal.

Authors:  Benjamin Van Tassell; George F Wohlford; Joyce D Linderman; Sheila Smith; Sahzene Yavuz; Frank Pucino; Francesco S Celi
Journal:  Thyroid       Date:  2019-09-12       Impact factor: 6.568

Review 2.  The emergence of levothyroxine as a treatment for hypothyroidism.

Authors:  James V Hennessey
Journal:  Endocrine       Date:  2016-12-16       Impact factor: 3.633

Review 3.  Thyroid hormone therapy in congenital hypothyroidism and pediatric hypothyroidism.

Authors:  Andrew J Bauer; Ari J Wassner
Journal:  Endocrine       Date:  2019-07-26       Impact factor: 3.633

4.  Thyroid Disease: Perspectives and Health Impacts.

Authors:  Betty M Drees; Brandon Barthel; Rajib K Bhattacharya
Journal:  Mo Med       Date:  2022 Jul-Aug

Review 5.  Thyroxine and treatment of hypothyroidism: seven decades of experience.

Authors:  Roselyn Cristelle I Mateo; James V Hennessey
Journal:  Endocrine       Date:  2019-07-18       Impact factor: 3.633

6.  Divergent prognostic effects of pre-existing and treatment-emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors.

Authors:  Mitchell S von Itzstein; Amrit S Gonugunta; Yiqing Wang; Thomas Sheffield; Rong Lu; Sadia Ali; Farjana J Fattah; Donglu Xie; Jennifer Cai; Yang Xie; David E Gerber
Journal:  Cancer Immunol Immunother       Date:  2022-01-24       Impact factor: 6.630

Review 7.  Management of hypothyroidism with combination thyroxine (T4) and triiodothyronine (T3) hormone replacement in clinical practice: a review of suggested guidance.

Authors:  Colin Dayan; Vijay Panicker
Journal:  Thyroid Res       Date:  2018-01-17

8.  Effects of Long-Term Combination LT4 and LT3 Therapy for Improving Hypothyroidism and Overall Quality of Life.

Authors:  Anam Tariq; Yijin Wert; Pramil Cheriyath; Renu Joshi
Journal:  South Med J       Date:  2018-06       Impact factor: 0.954

9.  Patient Experiences and Perceptions Associated with the Use of Desiccated Thyroid Extract.

Authors:  Freddy J K Toloza; Nataly R Espinoza Suarez; Omar El Kawkgi; Elizabeth H Golembiewski; Oscar J Ponce; Lixia Yao; Spyridoula Maraka; Naykky M Singh Ospina; Juan P Brito
Journal:  Medicina (Kaunas)       Date:  2020-04-03       Impact factor: 2.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.